Aaron Lin is a medical student at the University of Birmingham in the UK. His focus is primarily in secondary research, with several systematic reviews and meta-analyses publications on complications and progneses following upper Gastro-intestinal surgery. He also conducts several audits a year, focusing on the standard of care for chemotherapy patients with early signs of neutropenic sepsis. Aaron is passionate about medical innovation, and currently serves as the Chief Operating Officer of Mindset Technologies, who have developed the world’s first AI powered dementia screening app. He is also passionate about medical education, and has served as the Program Coordinator for AAMS since 2017.